Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

Ann Intern Med. 2001 Feb 6;134(3):191-202.

PMID:
11177331
2.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
3.

Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.

Kearon C.

Curr Opin Pulm Med. 2007 Sep;13(5):398-402. Review.

PMID:
17940484
4.
5.

Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.

Wellington K, McClellan K, Jarvis B.

Drugs. 2001;61(8):1185-209. Review.

PMID:
11465877
7.
8.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.

Robertson L, Jones LE.

Cochrane Database Syst Rev. 2017 Feb 9;2:CD001100. doi: 10.1002/14651858.CD001100.pub4. Review.

PMID:
28182249
9.

Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.

Pineo GF, Hull RD.

Baillieres Clin Haematol. 1998 Sep;11(3):621-37. Review.

PMID:
10331096
10.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E.

Cochrane Database Syst Rev. 2000;(2):CD001100. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001100.

PMID:
10796593
11.
12.

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Holzheimer RG.

Eur J Med Res. 2004 Apr 30;9(4):225-39. Review.

PMID:
15210403
13.

Long-term treatment of venous thromboembolism with low-molecular-weight heparin.

Monreal M.

Curr Opin Pulm Med. 2000 Jul;6(4):326-9. Review.

PMID:
10912641
14.

Low-molecular-weight heparin in the treatment of pulmonary embolism.

Ageno W, Turpie AG.

Semin Vasc Surg. 2000 Sep;13(3):189-93. Review.

PMID:
11005462
15.

Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

van Dongen CJ, Mac Gillavry MR, Prins MH.

Cochrane Database Syst Rev. 2003;(1):CD003074. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003074.

PMID:
12535452
16.

Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

van Dongen CJ, MacGillavry MR, Prins MH.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003074. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003074.

PMID:
16034885
17.

[Low molecular weight heparin].

Pini M.

Recenti Prog Med. 1997 Dec;88(12):594-602. Review. Italian.

PMID:
9522605
18.

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001.

PMID:
11034739
19.

Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.

Raskob GE.

Curr Opin Pulm Med. 1999 Jul;5(4):216-21. Review.

PMID:
10407690
20.

Supplemental Content

Support Center